rs72929434

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001122955.4(BSCL2):​c.486+11G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.206 in 1,603,676 control chromosomes in the GnomAD database, including 35,706 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2343 hom., cov: 31)
Exomes 𝑓: 0.21 ( 33363 hom. )

Consequence

BSCL2
NM_001122955.4 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.711

Publications

7 publications found
Variant links:
Genes affected
BSCL2 (HGNC:15832): (BSCL2 lipid droplet biogenesis associated, seipin) This gene encodes the multi-pass transmembrane protein protein seipin. This protein localizes to the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Naturally occurring read-through transcription occurs between this locus and the neighboring locus HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2).[provided by RefSeq, Mar 2011]
HNRNPUL2-BSCL2 (HGNC:49189): (HNRNPUL2-BSCL2 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2) and BSCL2 (Berardinelli-Seip congenital lipodystrophy 2 (seipin)) genes on chromosome 11. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001122955.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 11-62702457-C-A is Benign according to our data. Variant chr11-62702457-C-A is described in ClinVar as Benign. ClinVar VariationId is 257497.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.219 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001122955.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BSCL2
NM_001122955.4
MANE Select
c.486+11G>T
intron
N/ANP_001116427.1Q96G97-4
BSCL2
NM_001386027.1
c.486+11G>T
intron
N/ANP_001372956.1J3KQ12
BSCL2
NM_001386028.1
c.486+11G>T
intron
N/ANP_001372957.1Q96G97-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BSCL2
ENST00000360796.10
TSL:1 MANE Select
c.486+11G>T
intron
N/AENSP00000354032.5Q96G97-4
BSCL2
ENST00000405837.5
TSL:1
c.486+11G>T
intron
N/AENSP00000385332.1J3KQ12
BSCL2
ENST00000407022.7
TSL:1
c.294+11G>T
intron
N/AENSP00000384080.3Q96G97-2

Frequencies

GnomAD3 genomes
AF:
0.168
AC:
25591
AN:
152010
Hom.:
2343
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.197
Gnomad AMR
AF:
0.139
Gnomad ASJ
AF:
0.161
Gnomad EAS
AF:
0.0910
Gnomad SAS
AF:
0.174
Gnomad FIN
AF:
0.126
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.222
Gnomad OTH
AF:
0.176
GnomAD2 exomes
AF:
0.175
AC:
43944
AN:
250708
AF XY:
0.180
show subpopulations
Gnomad AFR exome
AF:
0.112
Gnomad AMR exome
AF:
0.136
Gnomad ASJ exome
AF:
0.157
Gnomad EAS exome
AF:
0.0835
Gnomad FIN exome
AF:
0.131
Gnomad NFE exome
AF:
0.223
Gnomad OTH exome
AF:
0.171
GnomAD4 exome
AF:
0.210
AC:
304831
AN:
1451548
Hom.:
33363
Cov.:
31
AF XY:
0.209
AC XY:
151016
AN XY:
722588
show subpopulations
African (AFR)
AF:
0.108
AC:
3600
AN:
33256
American (AMR)
AF:
0.136
AC:
6044
AN:
44552
Ashkenazi Jewish (ASJ)
AF:
0.159
AC:
4138
AN:
26004
East Asian (EAS)
AF:
0.102
AC:
4016
AN:
39542
South Asian (SAS)
AF:
0.171
AC:
14670
AN:
86002
European-Finnish (FIN)
AF:
0.138
AC:
7310
AN:
53126
Middle Eastern (MID)
AF:
0.173
AC:
992
AN:
5746
European-Non Finnish (NFE)
AF:
0.229
AC:
252815
AN:
1103404
Other (OTH)
AF:
0.188
AC:
11246
AN:
59916
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
11431
22862
34292
45723
57154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8528
17056
25584
34112
42640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.168
AC:
25591
AN:
152128
Hom.:
2343
Cov.:
31
AF XY:
0.164
AC XY:
12192
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.111
AC:
4604
AN:
41496
American (AMR)
AF:
0.139
AC:
2129
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.161
AC:
558
AN:
3472
East Asian (EAS)
AF:
0.0908
AC:
470
AN:
5174
South Asian (SAS)
AF:
0.173
AC:
835
AN:
4822
European-Finnish (FIN)
AF:
0.126
AC:
1332
AN:
10580
Middle Eastern (MID)
AF:
0.184
AC:
54
AN:
294
European-Non Finnish (NFE)
AF:
0.222
AC:
15059
AN:
67982
Other (OTH)
AF:
0.175
AC:
370
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1062
2124
3185
4247
5309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.188
Hom.:
1024
Bravo
AF:
0.165
Asia WGS
AF:
0.127
AC:
443
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
Congenital generalized lipodystrophy type 2 (2)
-
-
2
not provided (2)
-
-
1
Charcot-Marie-Tooth disease type 2 (1)
-
-
1
Hereditary spastic paraplegia 17 (1)
-
-
1
Neuronopathy, distal hereditary motor, type 5A (1)
-
-
1
Neuronopathy, distal hereditary motor, type 5C (1)
-
-
1
Severe neurodegenerative syndrome with lipodystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
8.7
DANN
Benign
0.88
PhyloP100
0.71
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs72929434;
hg19: chr11-62469929;
COSMIC: COSV54015955;
COSMIC: COSV54015955;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.